Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta‐analysis

BACKGROUND AND AIMS: Lymphoma patients are frequently treated with cancer therapies that may increase the risk of adverse health outcomes later in life, including cardiovascular disease (CVD) mortality. We sought to investigate the long‐term risk of CVD incidence in this survivor population relative...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Chelsea R., Mickle, Alexis T., Boyne, Devon J., Mohamed, Aliya, Rabi, Doreen M., Brenner, Darren R., Friedenreich, Christine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811739/
https://www.ncbi.nlm.nih.gov/pubmed/31667360
http://dx.doi.org/10.1002/hsr2.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811739/
https://www.ncbi.nlm.nih.gov/pubmed/31667360
http://dx.doi.org/10.1002/hsr2.135

Ejemplares similares